Bristol-Myers Squibb to Hold Investor Webcast to Discuss ESMO Highlights

NEW YORK--()--Bristol-Myers Squibb Company (NYSE: BMY) will host a webcast on Saturday, September 28, 2019 at 7:30 p.m. CEST (1:30 p.m. EDT) to discuss data presented at the European Society of Medical Oncology, in Barcelona, Spain. Company executives will provide an overview of data presented at the meeting, with a focus on the company’s Immuno-Oncology portfolio, and address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast at: investor.bms.com and are urged to register prior to the webcast. Materials related to the call will be available at the same website prior to the call.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

Contacts

Media:
Carrie Fernandez, 609-252-5222, carrie.fernandez@bms.com

Investors:
Tim Power, 609-252-7509, timothy.power@bms.com

Release Summary

Bristol-Myers Squibb to Hold Investor Webcast to Discuss ESMO Highlights

Contacts

Media:
Carrie Fernandez, 609-252-5222, carrie.fernandez@bms.com

Investors:
Tim Power, 609-252-7509, timothy.power@bms.com